This presentation is an overview of the MAPS-funded study of long-term outcomes for ibogaine-assisted treatment of opiate dependence for patients at two clinics in Baja California, Mexico. Beginning in September of 2010, the study enrolled thirty US residents seeking ibogaine treatment for opiate dependence at the clinics.
The study used the Addiction Severity Index to assess each subject’s severity of drug addiction at enrollment into the study and then monthly after treatment for twelve months. The 12-month follow-up of the 30th participant was completed in September of 2012, and currently the MAPS team is analysing the data and preparing a manuscript for publication.